Health Canada Greenlights Kashiv’s Pegfilgrastim Biosimilar
The Drug Will Be Sold As Pexegra By Local Partner JAMP Pharma
After receiving an approval for the Neulasta rival in the US in May 2022, Kashiv BioSciences has now added a further North American country with a positive nod from Canada’s health agency.
